Phelligridin D from Inonotus obliquus attenuates oxidative stress and accumulation of ECM in mesangial cells under high glucose via activating Nrf2.

From the paper

Abstract

Diabetic nephropathy (DN) is one of the most common microvascular complications of diabetes mellitus and becomes the financial burden and health problem. Pathogenesis of DN has revealed that high glucose has resulted in the oxidative stress and accumulation of extracellular matrix (ECM). Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor regulating the expression of anti-oxidant enzymes. Therefore, activating Nrf2 gives a promising approach for the treatment of DN. In the discovery of bioactive phytochemicals targeting DN, we have identified phelligridin D from Inonotus obliquus and explored its protective effects against oxidative stress and accumulation of ECM using mesangial cells under high glucose and potential mechanisms. In addition to inhibiting the self-limited proliferation of mesangial cells cultured in high glucose, phelligridin D can attenuate oxidative stress through reducing reactive oxygen species (ROS) and malondialdehyde (MDA) as well as elevating the activity of superoxide dismutase (SOD) and catalase (CAT). Meanwhile, the major components of ECM including collagen IV, fibronectin and laminin were decreased by phelligridin D via inhibiting the secretion of transforming growth factor-β1 (TGF-β1) and downstream connective tissue growth factor (CTGF). Further investigations have revealed phelligridin D activated Nrf2 in mesangial cells under high glucose, which was involved in its protective effects. These findings can provide evidences for the discovery of novel therapy targeting DN and application of I. obliquus in practice.